Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Protara Therapeutics (TARA) Amortization - Intangibles (2022 - 2026)

Protara Therapeutics' Amortization - Intangibles history spans 5 years, with the latest figure at $183000.0 for Q1 2026.

  • Quarterly Amortization - Intangibles rose 10.24% to $183000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Mar 2026, up 46.09% year-over-year, with the annual reading at $1.3 million for FY2025, 61.68% up from the prior year.
  • Amortization - Intangibles came in at $183000.0 for Q1 2026, down from $316000.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $444000.0 in Q3 2024 to a low of -$346000.0 in Q2 2022.
  • The 5-year median for Amortization - Intangibles is $130000.0 (2023), against an average of $126687.5.
  • Year-over-year, Amortization - Intangibles tumbled 94.7% in 2024 and then soared 5457.14% in 2025.
  • Protara Therapeutics' Amortization - Intangibles stood at -$107000.0 in 2022, then soared by 204.67% to $112000.0 in 2023, then surged by 158.93% to $290000.0 in 2024, then increased by 8.97% to $316000.0 in 2025, then tumbled by 42.09% to $183000.0 in 2026.
  • Per Business Quant, the three most recent readings for TARA's Amortization - Intangibles are $183000.0 (Q1 2026), $316000.0 (Q4 2025), and $437000.0 (Q3 2025).